SCHEMBL3610461

SCHEMBL3610461

CCCCOC1CC(C)(C)[NH+]([O-])C(C)(C)C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8848740 0.93 GBA1 (0.38) EPHX2
SCHEMBL1138466 0.90
SCHEMBL18149059 0.80
SCHEMBL16711496 0.78 GBA1 (0.38) EPHX2
SCHEMBL16985430 0.75 EPHX2 (0.35) EPHX2
SCHEMBL16730883 0.75 ADRB2 (0.36) EPHX2
SCHEMBL12545145 0.74 MEN1 (0.37)
SCHEMBL12214257 0.73 GAA (0.33) EPHX2
SCHEMBL11168513 0.72 EPHX2 (0.31) EPHX2
SCHEMBL2437027 0.70 EPHX2 (0.33) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4628479-A2 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS Ecolab USA Inc. (US) 2025-10-08 EP claimed
US-10155705-B2 Sterically hindered hydroquinones as antifoulants for unsaturated monomers ECOLAB USA INC. (US) 2018-12-18 US claimed
EP-3289046-A1 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS Ecolab USA Inc. (US) 2018-03-07 EP claimed
CN-107532083-A Steric hindrance quinhydrones is used for unsaturated monomer as anti-fouling agent 艺康美国股份有限公司 2018-01-02 CN claimed
WO-2016172076-A1 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS ECOLAB USA INC. (US) 2016-10-27 WO claimed
US-20160304417-A1 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS ECOLAB USA INC. 2016-10-20 US claimed
US-20100168434-A1 INHIBITION OF POLYMERISATION A H MARKS AND COMPANY LIMITED (GB) 2010-07-01 US claimed
EP-1937726-A1 INHIBITION OF POLYMERISATION A H Marks & Company Limited (GB) 2008-07-02 EP claimed
WO-2007045886-A1 INHIBITION OF POLYMERISATION A H MARKS AND COMPANY LIMITED (GB) 2007-04-26 WO claimed
US-5631366-A OXIDATION OF CEPHEM ALCOHOL TO ALDEHYDE USING HYPOHALITE OR INORGANIC HALITE IN THE PRESENCE OF PIPERIDINE OXIDES HOFFMANN-LA ROCHE INC. (US) 1997-05-20 US claimed
US-20250340794-A1 COMPOSITION WITH FATTY ACID DERIVATIVES AND USE IN INDUSTRIAL PROCESSES ECOLAB USA INC (US) 2025-11-06 US disclosed
EP-4628479-A2 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS Ecolab USA Inc. (US) 2025-10-08 EP disclosed
US-11186540-B2 Anti-foulant formulation for compressors ECOLAB USA INC. (US) 2021-11-30 US disclosed
CN-110337488-B Antifouling agent formulation for compressor 埃科莱布美国股份有限公司 2021-11-16 CN disclosed
US-20200339504-A1 ANTI-FOULANT FORMULATION FOR COMPRESSORS ECOLAB USA INC. 2020-10-29 US disclosed
WO-2016172076-A1 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS ECOLAB USA INC. (US) 2016-10-27 WO disclosed
US-20160304417-A1 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS ECOLAB USA INC. 2016-10-20 US disclosed
US-20100168434-A1 INHIBITION OF POLYMERISATION A H MARKS AND COMPANY LIMITED (GB) 2010-07-01 US disclosed
EP-1937726-A1 INHIBITION OF POLYMERISATION A H Marks & Company Limited (GB) 2008-07-02 EP disclosed
WO-2007045886-A1 INHIBITION OF POLYMERISATION A H MARKS AND COMPANY LIMITED (GB) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304417-A1 STERICALLY HINDERED HYDROQUINONES AS ANTIFOULANTS FOR UNSATURATED MONOMERS ALOX15, ALOX5, ALOX15B EPHX2 282/4885
US-20100168434-A1 INHIBITION OF POLYMERISATION NOS2, NOS1, NOS3 EPHX2 159/4885
US-10155705-B2 Sterically hindered hydroquinones as antifoulants for unsaturated monomers ALOX15, ALOX5, ALOX15B EPHX2 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.